MSMaytal Saar-Tsechansky

Maytal Saar-Tsechansky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maytal Saar-Tsechansky has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Machine Learning Framework for Assessing Experts’ Decision Quality

    by Wanxue Dong, Maytal Saar-Tsechansky, Tomer Geva

    Expert workers make non-trivial decisions with significant implications. Experts’ decision accuracy is, thus, a fundamental aspect of their judgment quality, key to both management and consumers of experts’ services. Yet, in many important settings, transparency in experts’ decision quality is rarely possible because ground truth data for evaluating the experts’ decisions is costly and available only for a limited set of decisions. Furthermore, different experts typically handle exclusive sets of decisions, and thus, prior solutions that rely on the aggregation of multiple experts’ decisions for the same instance are inapplicable. We first formulate the problem of estimating experts’ decision accuracy in this setting and then develop a machine–learning–based framework to address it. Our method effectively leverages both abundant historical data on workers’ past decisions and scarce decision instances with ground truth labels. Using both semi-synthetic data based on publicly available data sets and purposefully compiled data sets on real workers’ decisions, we conduct extensive empirical evaluations of our method’s performance relative to alternatives. The results show that our approach is superior to existing alternatives across diverse settings, including settings that involve different data domains, experts’ qualities, and amounts of ground truth data. To our knowledge, this paper is the first to posit and address the problem of estimating experts’ decision accuracies from historical data with scarce ground truth, and it is the first to offer comprehensive results for this problem setting, establishing the performances that can be achieved across settings as well as the state-of-the-art performance on which future work can build. This paper was accepted by Anindya Ghose, information systems. Funding: T. Geva acknowledges research grants from the Jeremy Coller Foundation and from the Henry Crown Institute for Business Research. Supplemental Material: The online appendix and data files are available at https://doi.org/10.1287/mnsc.2021.03357 .


  • Top Cited Papers

    Megastudy testing 25 treatments to reduce antidemocratic attitudes and partisan animosity

    by Jan G. Voelkel, Michael N. Stagnaro, James Y. Chu, Sophia L. Pink, Joseph S. Mernyk, Chrystal Redekopp, Isaias Ghezae, Matthew Cashman, Dhaval Adjodah, Levi G. Allen, et al.

    Scholars warn that partisan divisions in the mass public threaten the health of American democracy. We conducted a megastudy ( n = 32,059 participants) testing 25 treatments designed by academics and practitioners to reduce Americans’ partisan animosity and antidemocratic attitudes. We find that many treatments reduced partisan animosity, most strongly by highlighting relatable sympathetic individuals with different political beliefs or by emphasizing common identities shared by rival partisans. We also identify several treatments that reduced support for undemocratic practices—most strongly by correcting misperceptions of rival partisans’ views or highlighting the threat of democratic collapse—which shows that antidemocratic attitudes are not intractable. Taken together, the study’s findings identify promising general strategies for reducing partisan division and improving democratic attitudes, shedding theoretical light on challenges facing American democracy.


  • Data-Driven Allocation of Preventive Care with Application to Diabetes Mellitus Type II

    by Mathias Kraus, Stefan Feuerriegel, Maytal Saar-Tsechansky

    Problem definition: Increasing costs of healthcare highlight the importance of effective disease prevention. However, decision models for allocating preventive care are lacking. Methodology/results: In this paper, we develop a data-driven decision model for determining a cost-effective allocation of preventive treatments to patients at risk. Specifically, we combine counterfactual inference, machine learning, and optimization techniques to build a scalable decision model that can exploit high-dimensional medical data, such as the data found in modern electronic health records. Our decision model is evaluated based on electronic health records from 89,191 prediabetic patients. We compare the allocation of preventive treatments (metformin) prescribed by our data-driven decision model with that of current practice. We find that if our approach is applied to the U.S. population, it can yield annual savings of $1.1 billion. Finally, we analyze the cost-effectiveness under varying budget levels. Managerial implications: Our work supports decision making in health management, with the goal of achieving effective disease prevention at lower costs. Importantly, our decision model is generic and can thus be used for effective allocation of preventive care for other preventable diseases.Funding: M. Kraus acknowledges funding from Bundesministerium für Bildung und Forschung [Grant 01IS22080]. S. Feuerriegel acknowledges funding from Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung [Grant 186932].Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2021.0251 .


  • Open Access

    Data-Driven Allocation of Preventive Care With Application to Diabetes Mellitus Type II

    by Mathias Kraus, Stefan Feuerriegel, Maytal Saar-Tsechansky

    Problem Definition. Increasing costs of healthcare highlight the importance of effective disease prevention. However, decision models for allocating preventive care are lacking. Methodology/Results. In this paper, we develop a data-driven decision model for determining a cost-effective allocation of preventive treatments to patients at risk. Specifically, we combine counterfactual inference, machine learning, and optimization techniques to build a scalable decision model that can exploit high-dimensional medical data, such as the data found in modern electronic health records. Our decision model is evaluated based on electronic health records from 89,191 prediabetic patients. We compare the allocation of preventive treatments (metformin) prescribed by our data-driven decision model with that of current practice. We find that if our approach is applied to the U.S. population, it can yield annual savings of $1.1 billion. Finally, we analyze the cost-effectiveness under varying budget levels. Managerial Implications. Our work supports decision-making in health management, with the goal of achieving effective disease prevention at lower costs. Importantly, our decision model is generic and can thus be used for effective allocation of preventive care for other preventable diseases.

  • How Can IJDS Authors, Reviewers, and Editors Use (and Misuse) Generative AI?

    by Galit Shmueli, Bianca Maria Colosimo, David Martens, Rema Padman, Maytal Saar-Tsechansky, Olivia R. Liu Sheng, W. Nick Street, Kwok-Leung Tsui


  • Open Access

    Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study

    by Simon Schallmoser, Thomas Zueger, Mathias Kraus, Maytal Saar-Tsechansky, Christoph Stettler, Stefan Feuerriegel

    Background: Micro- and macrovascular complications are a major burden for individuals with diabetes and can already arise in a prediabetic state. To allocate effective treatments and to possibly prevent these complications, identification of those at risk is essential. Objective: This study aimed to build machine learning (ML) models that predict the risk of developing a micro- or macrovascular complication in individuals with prediabetes or diabetes. Methods: In this study, we used electronic health records from Israel that contain information about demographics, biomarkers, medications, and disease codes; span from 2003 to 2013; and were queried to identify individuals with prediabetes or diabetes in 2008. Subsequently, we aimed to predict which of these individuals developed a micro- or macrovascular complication within the next 5 years. We included 3 microvascular complications: retinopathy, nephropathy, and neuropathy. In addition, we considered 3 macrovascular complications: peripheral vascular disease (PVD), cerebrovascular disease (CeVD), and cardiovascular disease (CVD). Complications were identified via disease codes, and, for nephropathy, the estimated glomerular filtration rate and albuminuria were considered additionally. Inclusion criteria were complete information on age and sex and on disease codes (or measurements of estimated glomerular filtration rate and albuminuria for nephropathy) until 2013 to account for patient dropout. Exclusion criteria for predicting a complication were diagnosis of this specific complication before or in 2008. In total, 105 predictors from demographics, biomarkers, medications, and disease codes were used to build the ML models. We compared 2 ML models: logistic regression and gradient-boosted decision trees (GBDTs). To explain the predictions of the GBDTs, we calculated Shapley additive explanations values. Results: Overall, 13,904 and 4259 individuals with prediabetes and diabetes, respectively, were identified in our underlying data set. For individuals with prediabetes, the areas under the receiver operating characteristic curve for logistic regression and GBDTs were, respectively, 0.657 and 0.681 (retinopathy), 0.807 and 0.815 (nephropathy), 0.727 and 0.706 (neuropathy), 0.730 and 0.727 (PVD), 0.687 and 0.693 (CeVD), and 0.707 and 0.705 (CVD); for individuals with diabetes, the areas under the receiver operating characteristic curve were, respectively, 0.673 and 0.726 (retinopathy), 0.763 and 0.775 (nephropathy), 0.745 and 0.771 (neuropathy), 0.698 and 0.715 (PVD), 0.651 and 0.646 (CeVD), and 0.686 and 0.680 (CVD). Overall, the prediction performance is comparable for logistic regression and GBDTs. The Shapley additive explanations values showed that increased levels of blood glucose, glycated hemoglobin, and serum creatinine are risk factors for microvascular complications. Age and hypertension were associated with an elevated risk for macrovascular complications. Conclusions: Our ML models allow for an identification of individuals with prediabetes or diabetes who are at increased risk of developing micro- or macrovascular complications. The prediction performance varied across complications and target populations but was in an acceptable range for most prediction tasks.


  • Open Access

    Learning to Advise Humans in High-Stakes Settings

    by Nicholas Wolczynski, Maytal Saar-Tsechansky, Tong Wang

    Expert decision-makers (DMs) in high-stakes AI-assisted decision-making (AIaDM) settings receive and reconcile recommendations from AI systems before making their final decisions. We identify distinct properties of these settings which are key to developing AIaDM models that effectively benefit team performance. First, DMs incur reconciliation costs from exerting decision-making resources (e.g., time and effort) when reconciling AI recommendations that contradict their own judgment. Second, DMs in AIaDM settings exhibit algorithm discretion behavior (ADB), i.e., an idiosyncratic tendency to imperfectly accept or reject algorithmic recommendations for any given decision task. The human's reconciliation costs and imperfect discretion behavior introduce the need to develop AI systems which (1) provide recommendations selectively, (2) leverage the human partner's ADB to maximize the team's decision accuracy while regularizing for reconciliation costs, and (3) are inherently interpretable. We refer to the task of developing AI to advise humans in AIaDM settings as learning to advise and we address this task by first introducing the AI-assisted Team (AIaT)-Learning Framework. We instantiate our framework to develop TeamRules (TR): an algorithm that produces rule-based models and recommendations for AIaDM settings. TR is optimized to selectively advise a human and to trade-off reconciliation costs and team accuracy for a given environment by leveraging the human partner's ADB. Evaluations on synthetic and real-world benchmark datasets with a variety of simulated human accuracy and discretion behaviors show that TR robustly improves the team's objective across settings over interpretable, rule-based alternatives.

  • Open Access

    Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study (Preprint)

    by Simon Schallmoser, Thomas Zueger, Mathias Kraus, Maytal Saar-Tsechansky, Christoph Stettler, Stefan Feuerriegel

    BACKGROUND Micro- and macrovascular complications are a major burden for individuals with diabetes and can already arise in a prediabetic state. To allocate effective treatments and to possibly prevent these complications, identification of those at risk is essential. OBJECTIVE This study aimed to build machine learning (ML) models that predict the risk of developing a micro- or macrovascular complication in individuals with prediabetes or diabetes. METHODS In this study, we used electronic health records from Israel that contain information about demographics, biomarkers, medications, and disease codes; span from 2003 to 2013; and were queried to identify individuals with prediabetes or diabetes in 2008. Subsequently, we aimed to predict which of these individuals developed a micro- or macrovascular complication within the next 5 years. We included 3 microvascular complications: retinopathy, nephropathy, and neuropathy. In addition, we considered 3 macrovascular complications: peripheral vascular disease (PVD), cerebrovascular disease (CeVD), and cardiovascular disease (CVD). Complications were identified via disease codes, and, for nephropathy, the estimated glomerular filtration rate and albuminuria were considered additionally. Inclusion criteria were complete information on age and sex and on disease codes (or measurements of estimated glomerular filtration rate and albuminuria for nephropathy) until 2013 to account for patient dropout. Exclusion criteria for predicting a complication were diagnosis of this specific complication before or in 2008. In total, 105 predictors from demographics, biomarkers, medications, and disease codes were used to build the ML models. We compared 2 ML models: logistic regression and gradient-boosted decision trees (GBDTs). To explain the predictions of the GBDTs, we calculated Shapley additive explanations values. RESULTS Overall, 13,904 and 4259 individuals with prediabetes and diabetes, respectively, were identified in our underlying data set. For individuals with prediabetes, the areas under the receiver operating characteristic curve for logistic regression and GBDTs were, respectively, 0.657 and 0.681 (retinopathy), 0.807 and 0.815 (nephropathy), 0.727 and 0.706 (neuropathy), 0.730 and 0.727 (PVD), 0.687 and 0.693 (CeVD), and 0.707 and 0.705 (CVD); for individuals with diabetes, the areas under the receiver operating characteristic curve were, respectively, 0.673 and 0.726 (retinopathy), 0.763 and 0.775 (nephropathy), 0.745 and 0.771 (neuropathy), 0.698 and 0.715 (PVD), 0.651 and 0.646 (CeVD), and 0.686 and 0.680 (CVD). Overall, the prediction performance is comparable for logistic regression and GBDTs. The Shapley additive explanations values showed that increased levels of blood glucose, glycated hemoglobin, and serum creatinine are risk factors for microvascular complications. Age and hypertension were associated with an elevated risk for macrovascular complications. CONCLUSIONS Our ML models allow for an identification of individuals with prediabetes or diabetes who are at increased risk of developing micro- or macrovascular complications. The prediction performance varied across complications and target populations but was in an acceptable range for most prediction tasks.

  • Open Access

    More for less: adaptive labeling payments in online labor markets

    by Tomer Geva, Maytal Saar-Tsechansky, Harel Lustiger


  • Open Access

    A scalable preference model for autonomous decision-making

    by Markus Peters, Maytal Saar-Tsechansky, Wolfgang Ketter, Sinead A. Williamson, Perry Groot, Tom Heskes